Recent Finacing
Recent Raise
OptiNose develops drug‑device combination products using a patented Bi‑Directional Breath Powered exhalation delivery system to deposit therapeutics deep in the nasal cavity for ENT, allergy, migraine, and CNS indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors